Literature DB >> 3276164

Potential for bias in case-control studies of oral contraceptives and breast cancer.

D C Skegg1.   

Abstract

Entities:  

Keywords:  Bias; Breast Cancer; Cancer; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods--side effects; Data Analysis; Data Collection; Diseases; Error Sources; Evaluation; Evaluation Methodology; Family Planning; Interviews; Measurement; Neoplasms; Oral Contraceptives--side effects; Reliability; Research Methodology; Sampling Errors; Survey Methodology; World

Mesh：

Substances：

Year:  1988        PMID： 3276164     DOI： 10.1093/oxfordjournals.aje.a114796

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  15 in total

1.  Evaluation of a prescription based record-linkage model for epidemiological studies of long-term adverse effects of drugs--with special regard to combined oral contraceptives.

Authors:  I Persson; H O Adami; S E Norell; B Westerholm; B E Wiholm
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Recent oral contraceptive use and risk of breast cancer (United States)

Authors:  P A Newcomb; M P Longnecker; B E Storer; R Mittendorf; J Baron; R W Clapp; A Trentham-Dietz; W C Willett
Journal:  Cancer Causes Control       Date:  1996-09       Impact factor: 2.506

Review 3.  Depot medroxyprogesterone acetate and breast cancer. A review of current knowledge.

Authors:  C E Chilvers
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

Review 4.  Oral contraceptives and cancer. A review of the evidence.

Authors:  C La Vecchia; A Tavani; S Franceschi; F Parazzini
Journal:  Drug Saf       Date:  1996-04       Impact factor: 5.606

5.  Oral contraceptive use and risk of breast cancer in older women (New Zealand).

Authors:  C Paul; D C Skegg; G F Spears
Journal:  Cancer Causes Control       Date:  1995-11       Impact factor: 2.506

6.  Exposure, susceptibility, and breast cancer risk: a hypothesis regarding exogenous carcinogens, breast tissue development, and social gradients, including black/white differences, in breast cancer incidence.

Authors:  N Krieger
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

Review 7.  Menopausal hormone therapy and breast cancer: what is the evidence from randomized trials?

Authors:  H N Hodis; P M Sarrel
Journal:  Climacteric       Date:  2018-10-09       Impact factor: 3.005

8.  Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study.

Authors:  Marit Busund; Nora S Bugge; Tonje Braaten; Marit Waaseth; Charlotta Rylander; Eiliv Lund
Journal:  Int J Cancer       Date:  2018-02-07       Impact factor: 7.396

Review 9.  Oral contraceptives and breast cancer.

Authors:  C E Chilvers; J M Deacon
Journal:  Br J Cancer       Date:  1990-01       Impact factor: 7.640

10.  Oral contraceptives and breast cancer.

Authors:  S S Jick; A M Walker; A Stergachis; H Jick
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.